CJC-1295
Growth Hormone Releasing Hormone Analog
30 Amino Acids · MW: 3,367.97 Da
Amino Acids
30
Molecular Weight
3,367.97 Da
Half-life
~6-8 days (DAC)
Research Score
4.6
Studies
167
Storage
N/A
What is CJC-1295?
CJC-1295 is a modified GHRH analog with an extended half-life due to Drug Affinity Complex (DAC) technology. It promotes sustained, pulsatile GH release, improving body composition, recovery, and sleep quality.
Key Benefits & Mechanisms
Sustained GH release over days
Improved body composition
Enhanced deep sleep quality
Accelerated recovery from training
Increased protein synthesis
Improved skin elasticity
Fat metabolism enhancement
Research Summary
CJC-1295 has good pre-clinical and early clinical data. The DAC variant shows sustained GH elevation for days. Often combined with GHRPs for synergistic GH release.
Related Peptides
BPC-157
Body Protection Compound
BPC-157 (Body Protection Compound-157) is a pentadecapeptide composed of 15 amino acids. It is a partial sequence of the body protection compound discovered in and isolated from human gastric juice. Extensive research demonstrates remarkable healing effects on tendons, muscles, the nervous system, and gastrointestinal tissue.
HealingIpamorelin
Growth Hormone Secretagogue
Ipamorelin is a selective growth hormone secretagogue that stimulates natural GH release without significantly affecting cortisol or prolactin levels. It is considered one of the safest and most selective GHRPs available.
PerformanceGHRP-6
Growth Hormone Releasing Peptide-6
GHRP-6 is a hexapeptide that stimulates the ghrelin receptor to promote growth hormone release. It is one of the earliest and most studied GH secretagogues, known for significant GH pulse induction and appetite stimulation.
PerformanceIGF-1 LR3
Insulin-like Growth Factor-1 Long R3
IGF-1 LR3 is a modified version of IGF-1 with 13 times the half-life of native IGF-1. It promotes anabolic signaling, muscle hyperplasia, and cellular repair with extended bioavailability.
Performance